Protalix Biotherapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protalix Biotherapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $86k | 68k | 1.26 |
| 2023-12-31 | $133k | 75k | 1.78 |
| 2023-09-30 | $62k | 37k | 1.66 |
| 2023-06-30 | $104k | 52k | 2.00 |
| 2023-03-31 | $9.9k | 4.7k | 2.10 |
| 2022-12-31 | $164 | 120 | 1.37 |
| 2022-09-30 | $0 | 11k | 0.00 |
| 2022-06-30 | $0 | 120 | 0.00 |
| 2022-03-31 | $0 | 120 | 0.00 |
| 2021-12-31 | $0 | 120 | 0.00 |
| 2021-09-30 | $0 | 2.3k | 0.00 |
| 2021-06-30 | $0 | 1.9k | 0.00 |
| 2021-03-31 | $9.8k | 2.2k | 4.44 |
| 2020-12-31 | $4.8k | 1.2k | 4.00 |
| 2020-09-30 | $17k | 4.5k | 3.77 |
| 2020-06-30 | $14k | 3.7k | 3.83 |
| 2020-03-31 | $0 | 179 | 0.00 |
| 2019-12-31 | $0 | 50 | 0.00 |